Biora Therapeutics Statistics Share Statistics Biora Therapeutics has 9.25M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 9.25M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 4.77M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 21.03M, so 0% of the outstanding
shares have been sold short.
Short Interest 21.03M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 6.07
Valuation Ratios The PE ratio is -0.32 and the forward
PE ratio is null.
Biora Therapeutics's PEG ratio is
0.04.
PE Ratio -0.32 Forward PE n/a PS Ratio 46.11 Forward PS n/a PB Ratio -0.68 P/FCF Ratio -0.34 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Biora Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.6,
with a Debt / Equity ratio of 0.
Current Ratio 1.6 Quick Ratio 1.6 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -18.59
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $10.06K Profits Per Employee $-1.44M Employee Count 124 Asset Turnover 0.01 Inventory Turnover n/a
Taxes Income Tax -119K Effective Tax Rate 0.07%
Stock Price Statistics The stock price has increased by -0.51% in the
last 52 weeks. The beta is 0, so Biora Therapeutics's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change -0.51% 50-Day Moving Average 1.17 200-Day Moving Average n/a Relative Strength Index (RSI) 38.22 Average Volume (20 Days) 6,366,301
Income Statement In the last 12 months, Biora Therapeutics had revenue of 1.25M
and earned -178.52M
in profits. Earnings per share was -6.49.
Revenue 1.25M Gross Profit 1.25M Operating Income -234.9M Net Income -178.52M EBITDA -233.46M EBIT -166M Earnings Per Share (EPS) -6.49
Full Income Statement Balance Sheet The company has 88.4M in cash and 0 in
debt, giving a net cash position of 88.4M.
Cash & Cash Equivalents 88.4M Total Debt n/a Net Cash n/a Retained Earnings -788.69M Total Assets 86.74M Working Capital 28.3M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -167.49M
and capital expenditures -855K, giving a free cash flow of -168.34M.
Operating Cash Flow -167.49M Capital Expenditures -855K Free Cash Flow -168.34M FCF Per Share -6.12
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -18836.81% and -14316.04%.
Gross Margin 100% Operating Margin -18836.81% Pretax Margin -14325.58% Profit Margin -14316.04% EBITDA Margin -18721.57% EBIT Margin -18836.81% FCF Margin -13499.68%
